Hello Interloper!
Menu
miraDry – a new treatment for the UK market
A new option for axillary hyperhidrosis patients is now available in the UK, known as miraDry. Developed in the USA, where is it now used in over 250 private clinics and medical centres, the miraDry procedure is the only FDA cleared treatment for axillary hyperhidrosis. The procedure is pain-free, non-invasive and does not involve toxins.
The treatment works by delivering precisely controlled electromagnetic energy to the armpit, which penetrates to the location of the sweat glands. The glands are thermally destroyed and the debris is naturally absorbed by the body. Sweat glands do not regenerate, so the reduction in sweat achieved is both immediate and lasting.
In clinical tests, an average 82% reduction in sweat was achieved after the recommended two treatments, spaced three months apart. Self-reported patient satisfaction levels are high, as measured on the review website Real Self, where it has achieved an excellent 92% rating based on 136 reviews. Side effects include temporary swelling and bruising which usually resolve in a matter of weeks. In addition, the procedure permanently reduces underarm hair, which is often viewed as a benefit, particularly by female patients. Odour is also reduced due to the destruction of apocrine glands, along with the sweat glands, which is another benefit of the treatment.
The International Hyperhidrosis Society (IHHS), the only independent, non-profit hyperhidrosis support organisation that operates globally, has recently updated its axillary hyperhidrosis (excessive underarm sweating) treatment pathway. The IHHS now places the use of microwave thermolysis (miraDry) as a second-line treatment option for physicians to recommend if their patients fail to respond to topical antiperspirant therapy.
This means that miraDry is now officially recognised by an international, independent body as an effective procedure and an excellent treatment option for people who suffer the inconvenience, anxiety and distress caused by excessive underarm sweat.
miraDry is an exciting development in the field of hyperhidrosis and should be considered as a possible option for any clinic that is currently treating hyperhidrosis patients. In contrast to toxin injections, miraDry provides a long lasting solution and is likely to permanently eliminate sweat glands. When compared to LSA, which also destroys the sweat glands, miraDry has a clinical evidence base and FDA approval.
Further information can be found at miraDry.co.uk.
Find a clinic providing miraDry treatment for axillary hyperhidrosis (excessive sweating).